Evaluating the Effect of Nurse-Led Stroke Transitional Care in Tanzania
NCT ID: NCT07319312
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
130 participants
OBSERVATIONAL
2025-08-01
2026-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nurse-led Rehabilitation to Improve Self-care Among Stroke Patients in Bangladesh
NCT06786559
Transitional Care Model for Patients With Stroke
NCT06280599
Effects Of Task-Oriented Training In Individuals With Stroke
NCT05671211
Self-supporting Care Model in Home Environment for Patients With Stroke
NCT04744324
Reduction of Recurrence of Stroke by Nurse-led Education in Bangladesh
NCT05520034
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Historical control group
Stroke survivors and their caregivers received usual care
Nurse-led stroke transitional care program
Participants in intervention group will receive usual care plus nurse-led stroke transitional care. Two nurse champions will conduct the face-to-face sessions while other two nurse researchers will conduct the telephone call sessions between August and December, 2025. During hospitalization, the two nurse champions will conduct five face-to-face sessions (2 individual sessions at admission; and at discharge), and three group sessions with 2-4 dyads of patients and caregivers. After hospitalization, two nurse researchers will conduct seven follow-up sessions for three months via phone calls at day 3, week 1, week 3, week 5, week 7, week 9, and week 11. The face-to-face sessions and phone call sessions will take 40-60 minutes and 20-30 minutes respectively
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nurse-led stroke transitional care program
Participants in intervention group will receive usual care plus nurse-led stroke transitional care. Two nurse champions will conduct the face-to-face sessions while other two nurse researchers will conduct the telephone call sessions between August and December, 2025. During hospitalization, the two nurse champions will conduct five face-to-face sessions (2 individual sessions at admission; and at discharge), and three group sessions with 2-4 dyads of patients and caregivers. After hospitalization, two nurse researchers will conduct seven follow-up sessions for three months via phone calls at day 3, week 1, week 3, week 5, week 7, week 9, and week 11. The face-to-face sessions and phone call sessions will take 40-60 minutes and 20-30 minutes respectively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical nurses and physicians with a minimum of diploma in their professions.
* Stroke survivors with 18 years old and above
* Stroke survivors admitted in the stroke units
* Stroke survivors with primary diagnosis of stroke confirmed by brain CT/MRI
* Stroke survivors who undergo usual discharge process
* Stroke survivors who live with their family caregivers
* Stroke survivors who have mobile phones
* Stroke survivors who can read and write
* Stroke survivors who are able to communicate
* Stroke survivors with National Institutes of Health Stroke Scale (NIHSS) \< 6
* Stroke survivors with Modified Barthel Index (MBI) \> 9
* Stroke survivors with Modified Rankin Scale (mRS) \< 5
* Stroke survivors with Montreal Cognitive Assessment Test (MoCA) \> 14
* Stroke survivors who are expected to stay in the ward for 3-5 days,
* Stroke survivors who are expected to survive for 3 months
* Family caregivers with mobile phones
* Family caregivers who can read and write
* Family caregivers who are able to communicate
* Family caregivers who live with the patient after stroke
Exclusion Criteria
* Stroke survivors with previous stroke who are not admitted in stroke units
* Stroke survivors who are discharged against medical advice
* Stroke survivors who have end-stage organ failure
* Stroke survivors who have family caregivers
* Stroke survivors who can't read/write
* Stroke survivors who have no mobile phones.
* Family caregivers without mobile phone that is accessible
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nyagwaswa Athanas Michael
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muhimbili University of Health and Allied Sciences
Dar es Salaam, , Tanzania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
72274110
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Shandong@2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.